Topic: Chronic kidney disease - Primary Care
Monday, 26 September 2011
Volume 4, Themed issue 1, September 2011.
Category: Themed Issues
Wednesday, 21 February 2018
This article seeks to demonstrate the close relationship between cardiovascular disease and chronic kidney disease (CKD). It also highlights the importance of identifying people with CKD as a means of recognising people at high risk of both cardiovascular events and unplanned admissions.
Sunday, 26 April 2009
Volume 2, Themed issue 1, September 2009.
Category: Themed Issues
Wednesday, 04 January 2017
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending extension of the label for all metformin-containing products to included patients with stable moderate renal failure (chronic kidney disease stage 3).
Tuesday, 10 April 2018
Heart failure (HF) is a devastating clinical syndrome characterised by a constellation of symptoms and signs in the presence of reduced cardiac function. Comorbidity is almost inherent as HF is often the culmination of chronic disease processes such as ischaemic heart disease, hypertension and valve disease and its treatment may precipitate comorbidities such as gout, erectile dysfunction (ED) and acute kidney injury (AKI).
Tuesday, 23 January 2018
Ischaemic or coronary heart disease is the single leading cause of death in any Western population but more critically is one of the leading causes of premature deaths (i.e. deaths 75 years) in both men and women. There are numerous risk factors for ischaemic heart disease and understanding these and other comorbidities is critical to achieving optimal outcomes.
Wednesday, 10 March 2021
Professor Cliff Bailey and Dr Pam Brown discuss the reno-protective effects of SGLT2 inhibitors and their role in the management diabetic kidney disease.
Sunday, 13 August 2017
The European Commission has approved patiromer (Veltassa®) for the treatment of hyperkalaemia, which marks the first new drug licenced specifically for the treatment of hyperkalaemia in over 60 years.
Friday, 15 September 2017
Healthcare professionals should offer statins to millions of people with chronic kidney disease (CKD) to help to manage their increased risk of cardiovascular disease (CVD), according to new guidance from NICE.